Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia

BackgroundThe Unified Dyskinesia Rating Scale (UDysRS) evaluates dyskinesia in patients with Parkinson's disease (PD). A minimal clinically important change (MCIC)—the smallest change in a treatment outcome that a patient considers important—remains undefined for the UDysRS.ObjectiveTo utilize...

Full description

Bibliographic Details
Main Authors: Rajesh Pahwa, Susan Fox, Robert A. Hauser, Stuart Isaacson, Judy Lytle, Reed Johnson, Lily Llorens, Andrea E. Formella, Caroline M. Tanner
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Neurology
Subjects:
minimal clinically important change
minimal clinically importance difference
Parkinson's disease
dyskinesia
amantadine
Movement Disorders
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.846126/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.846126/full

Similar Items